Literature DB >> 2817859

Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

W H Traub1, M Spohr.   

Abstract

A total of 144 clinical isolates of Acinetobacter species, i.e., A. baumannii (n = 60), genospecies 3 (n = 48), A. haemolyticus (n = 12), and genospecies 6 (n = 24), were examined comparatively with the agar dilution method of the National Committee for Clinical Laboratory Standards for susceptibility to 25 antimicrobial drugs. Only minor species differences were noted.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2817859      PMCID： PMC172714          DOI： 10.1128/AAC.33.9.1617

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.

Authors:  B P Overbeek; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

2.  Sensitivity of Acinetobacter calcoaceticus strains to seven cephalosporins.

Authors:  P C Appelbaum; J Tamim; J Stavitz; R C Aber
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

3.  In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.

Authors:  J V Crues; B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

4.  A report of a further hospital outbreak caused by a multi-resistant Acinetobacter anitratus.

Authors:  J Holton
Journal:  J Hosp Infect       Date:  1982-09       Impact factor: 3.926

5.  In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Authors:  I Garcia; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

6.  Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.

Authors:  A W Chow; J Wong; K H Bartlett
Journal:  Diagn Microbiol Infect Dis       Date:  1988-04       Impact factor: 2.803

7.  Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis.

Authors:  E Abrutyn; G L Goodhart; K Roos; R Anderson; A Buxton
Journal:  Am J Epidemiol       Date:  1978-04       Impact factor: 4.897

8.  In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus.

Authors:  Y Obana; T Nishino; T Tanino
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

9.  Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics.

Authors:  A E Buxton; R L Anderson; D Werdegar; E Atlas
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

10.  Acinetobacter calcoaceticus variety anitratus: an increasing nosocomial problem.

Authors:  R Ramphal; R M Kluge
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378
View more
  21 in total

1.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.

Authors:  M B Marques; E S Brookings; S A Moser; P B Sonke; K B Waites
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Antimicrobial susceptibility of Acinetobacter species.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting.

Authors:  Y Gräser; I Klare; E Halle; R Gantenberg; P Buchholz; H D Jacobi; W Presber; G Schönian
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Genetic diversity and clonal relationships of Acinetobacter baumannii strains isolated in a neonatal ward: epidemiological investigations by allozyme, whole-cell protein and antibiotic resistance analysis.

Authors:  V Thurm; E Ritter
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

7.  Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates.

Authors:  M Perilli; A Felici; A Oratore; G Cornaglia; G Bonfiglio; G M Rossolini; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Emergence of resistant isolates of Acinetobacter calcoaceticus- A. baumannii complex in a Spanish hospital over a five-year period.

Authors:  M I García-Arata; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

9.  Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus.

Authors:  E Castellanos Martínez; M Telenti Asensio; V M Rodríguez Blanco; M L Rodríguez Suárez; A Morena Torrico; A Cortina Llosa
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

10.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.